Organ-on-Chip technology involves the creation of miniature devices that mimic the structure and function of human organs. These microscale models are designed to replicate the behavior of living tissues in a lab setting.
Traditional drug testing methods often fail to accurately predict human responses due to species differences and the complexity of organ interactions. Organ-on-Chip technology addresses these limitations by providing a more physiologically relevant model for testing drug efficacy and toxicity.
These chips contain channels and chambers where cells from different organ types can be cultured, allowing for the simulation of complex biological interactions. Microfluidic systems control the flow of nutrients, oxygen, and other factors that mimic the physiological environment within an organism.
The manufacturing process involves microfabrication techniques, such as photolithography, to create intricate channels and chambers within a chip. Cells are then cultured on or in the chip to form functional miniaturized organs.
First, the microfluidic channels and structures are etched into a substrate using precise lithographic methods. Next, cell lines relevant to specific organ functions are seeded onto these surfaces. Finally, the chip is sealed to create a closed system where fluid can be introduced for nutrient delivery and waste removal.
Curated names only — none are invented. Use the link to find more.
Cost drivers only — no verified dollar figures are shown. Check live sources for prices.
Illustrative — search real, dated examples rather than trusting a generated story.
Live searches — we don't list papers we can't verify.
Live patent searches — filings are never listed from memory.
Verify against primary sources only.
Source: curated technology intelligence stream with tracked references.